Interestingly, several genes with potential oncogenic functions, such as SF3B1, FYN, and LCK, are also frequently downregulated but the physiological relevance of these changes for PTCL development remains unclear. The gene discussed is LCK; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.